The impact of legal cannabis availability on cannabis use and health outcomes: a systematic review

J Manthey, B Jacobsen, T Hayer, J Kalke… - International Journal of …, 2023 - Elsevier
Background For alcohol, regulating availability is an effective way to reduce consumption
and harm. Similarly, the higher availability of medical cannabis dispensaries has been …

Cannabis legalization and acute harm from high potency cannabis products: a narrative review and recommendations for public health

J Matheson, B Le Foll - Frontiers in psychiatry, 2020 - frontiersin.org
Legalization and commercial sale of non-medical cannabis has led to increasing diversity
and potency of cannabis products. Some of the American states that were the first to legalize …

Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets

S Goodman, E Wadsworth, C Leos-Toro… - International Journal of …, 2020 - Elsevier
Background Recreational or 'non-medical cannabis' has been legalized in several US
states, and was legalized federally in Canada in October 2018. There is little comparative …

Trends in the use of cannabis products in Canada and the USA, 2018–2020: Findings from the International Cannabis Policy Study

D Hammond, S Goodman, E Wadsworth… - International Journal of …, 2022 - Elsevier
Abstract Background and Aims There is little information on consumption patterns across the
diverse range of cannabis product types. This paper examines trends in consumption …

Use and perceptions of cannabidiol products in Canada and in the United States

S Goodman, E Wadsworth, G Schauer… - Cannabis and …, 2022 - liebertpub.com
Objectives: This study aimed to characterize use and perceptions of cannabidiol (CBD)
products. Materials and Methods: Participants aged 16–65 years in Canada (n= 15,042) and …

Identifying risk-thresholds for the association between frequency of cannabis use and development of cannabis use disorder: A systematic review and meta-analysis

T Robinson, MU Ali, B Easterbrook… - Drug and Alcohol …, 2022 - Elsevier
Background Cannabis use disorder (CUD) affects one-in-five cannabis users, presenting a
major contributor to cannabis-associated disease burden. Epidemiological data identify the …

The impact of cannabis legalization for recreational purposes on youth: a narrative review of the Canadian experience

DS Rubin-Kahana, JF Crépault, J Matheson… - Frontiers in …, 2022 - frontiersin.org
Cannabis legalization for non-medical purposes (subsequently referred to as “cannabis
legalization” or “legalization”) took place in Canada in October 2018. One of the federal …

Changes in health harms due to cannabis following legalisation of non‐medical cannabis in Canada in context of cannabis commercialisation: a scoping review

DT Myran, S Imtiaz, L Konikoff, L Douglas… - Drug and Alcohol …, 2023 - Wiley Online Library
Abstract Issue On 17 October 2018, Canada legalised non‐medical cannabis. Critically, the
cannabis market in Canada has changed considerably since legalisation. In this scoping …

Associations between Canada's cannabis legalization and emergency department presentations for transient cannabis-induced psychosis and schizophrenia …

RC Callaghan, M Sanches, RM Murray… - The Canadian …, 2022 - journals.sagepub.com
Objective Cannabis legalization in many jurisdictions worldwide has raised concerns that
such legislation might increase the burden of transient and persistent psychotic illnesses in …

Reasons for purchasing cannabis from illegal sources in legal markets: findings among Cannabis Consumers in Canada and US States, 2019–2020

S Goodman, E Wadsworth, D Hammond - … of studies on alcohol and drugs, 2022 - jsad.com
Objective: Nonmedical cannabis is legal in Canada and several US states. Displacing the
illegal market is a primary goal of legalization; however, there are little data on factors that …